ResMed | RMD - PE价格收益



金融业
股票价格
USD
资产
USD 8.97B
现金及等价物
USD 1.47B
销售成本
USD 612.93M
流动资产
USD 4.32B
流动负债
USD 1.4B
债务
USD 843.17M
股息收益率
0.28
EBIT
USD 454.34M
EBITDA
USD 559.78M
员工
10.6K
EPS每股收益
USD 2.95
股本和储备
USD 6.59B
销售毛利
USD 861.22M
债务利息支出
USD 8.79M
利息收入
USD 59K
贷款资金
USD 399.42M
市值
USD 32.92B
净收入
USD 383.43M
营业费用
USD 1.01B
营业利润
USD 454.34M
普通股股本
USD 145.06M
PE价格收益
18.29
税前利润
USD 502.31M
销售收入
USD 1.46B
销售和管理费用
USD 290.66M
股票
USD 911.88M
贸易债权人
USD 308.92M
应收帐款人
USD 1.04B


Pe 更改 日
Ansell 15.12 1.29 2025-12
Artivion 212.38 16.51 2025-12
AtriCure 129.01 94.86 2026-06
Baxter International 151.95 65.95 2026-06
Cochlear 43.67 9.72 2025-12
Cooper Companies 23.27 16.99 2026-03
CSL 16.16 9.59 2025-12
Dexcom 24.61 0.12 2026-06
Edwards Lifesciences 30.77 3.9 2026-06
Fisher Paykel Healthcare 44.27 3.47 2026-06
Globus Medical 22.31 12.99 2026-06
Haemonetics 17.35 1.82 2026-06
Idexx Laboratories 36.98 4.34 2026-06
Inogen 69.33 30.67 2021-09
Insulet 29.66 9.17 2026-06
Integra LifeSciences 10.28 5.21 2026-06
Intuitive Surgical 44.59 11.23 2026-06
Medtronic 19.66 3.1 2026-03
Philips 23.76 9.44 2026-06
Ramsay Health Care 25.59 0.37 2025-12
ResMed 18.29 2.92 2026-06
Sigma Healthcare 244.1 170.86 2024-12
Sonic Healthcare 24.87 0.21 2025-06
Steris 25.3 2.04 2026-06
Teleflex 89.77 40.52 2026-06
Thermo Fisher Scientific 26.4 1.31 2026-06